Active Pharmaceutical Ingredients Committee (Cefic)
The API industry's sector group within Cefic; author of the freely published "How to do" document that translates ICH Q7 into section-by-section manufacturing practice.
What this page does not claim
SPEQ curates and cross-references these bodies. It is not affiliated with, accredited by, or endorsed by any of them, and a count of decoded standards is a measure of SPEQ’s coverage, not of a body’s importance.
WHAT APIC COVERS
The Active Pharmaceutical Ingredients Committee is the API industry's sector group within Cefic, the European Chemical Industry Council — an industry body, not a regulator, and registered in SPEQ accordingly. Its place in the GxP canon rests on one durable contribution: the "How to do" document for ICH Q7, a section-by-section interpretation of the harmonised API GMP guide that describes how manufacturers implement each requirement in practice. Version 17 was finalised in November 2024 and, unusually for industry-body texts, is published free on apic.cefic.org. APIC maintains companion guidance on adjacent API topics — auditing, cleaning validation, supplier qualification — revised on a continuing cycle by its member-company experts.
WHAT APIC PUBLISHES
- 01The "How to do" document — interpretation of the ICH Q7 guide (v17, finalised November 2024; free PDF)
- 02Companion API guidance: auditing programmes, cleaning validation, and supplier-qualification documents
- 03Position papers on API regulatory topics from the industry perspective
HOW ITS REQUIREMENTS BITE
None — and that is the point to understand. APIC inspects nothing, certifies nothing, and its documents bind no one. Its texts acquire influence the way good industry guidance does: by being adopted into member and non-member quality systems as the consensus reading of ICH Q7, and by giving suppliers and auditors a common vocabulary for API GMP implementation. The regulatory standard remains ICH Q7 as adopted in each jurisdiction (EU GMP Part II, FDA-adopted guidance, PIC/S), and where APIC's interpretation and a regulator's reading diverge, the regulator's prevails.
What practitioners get wrong
- Cite Q7, not APIC, in anything regulators read: the "How to do" text is an implementation aid, and quoting it as the requirement substitutes industry interpretation for the regulatory standard.
- Check version currency — the document is revised repeatedly (currently v17), and superseded copies embedded in local SOPs are common.
- The free-publication model makes it uniquely usable: unlike most industry-body texts it can be distributed across a supplier base without licensing friction.
- APIC is the API-side sibling of IPEC: Q7 covers actives and not excipients, so the two bodies' guides divide the ingredient landscape between them.
WHERE IT SITS INTERNATIONALLY
APIC's work is anchored to ICH: the "How to do" document tracks ICH Q7's structure exactly and is revised as regulatory expectations evolve. It complements the IPEC-PQG excipient GMP guide (the parallel solution for the territory Q7 does not cover) and the EU's GDP guidelines for active substances downstream — together the industry-and-guidance stack around the API supply chain.
APIC STANDARDS SPEQ DECODES · 1
DISCIPLINES IN APIC’S REMIT
APIC: frequently asked questions
Reference answers on Active Pharmaceutical Ingredients Committee (Cefic)’s mandate, what it publishes, and how its requirements acquire force.
What is APIC?
The Active Pharmaceutical Ingredients Committee — the API industry's sector group within Cefic, the European Chemical Industry Council. It is an industry body whose best-known output is the free "How to do" interpretation of ICH Q7, currently version 17 (November 2024).
Is APIC guidance legally binding?
No. APIC regulates nothing; its documents are industry consensus on implementing ICH Q7, and the binding standard is always Q7 as adopted in the relevant jurisdiction. The value is practical: a shared, freely available reading of what good implementation looks like.
How does APIC relate to IPEC?
They are parallel industry bodies dividing the ingredient landscape: ICH Q7 governs active pharmaceutical ingredients, so APIC interprets it for API makers, while IPEC (with the PQG) authored the excipient GMP guide that fills the space Q7 deliberately leaves out.